Video
Author(s):
Panelists round out their review of staging and risk stratification in CSCC by considering how each affects the selection of optimal surgical strategies.
Exploring Unmet Needs to Optimize Neoadjuvant Therapy in Resectable CRC
Community Oncologists on the Importance of Self-Reliance and Collegial Trust as Women in Medicine
Adjuvant Nivolumab/Ipilimumab Lengthens DMFS in High-Risk Uveal Melanoma
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
OBX-115 Earns FDA Fast Track Designation for Advanced Melanoma
FDA Receives BLA Resubmission for Cosibelimab in Advanced CSCC
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC
Dr Herbst on the Importance of Multidisciplinary Collaboration in NSCLC